ViviGen Health Economics

VARIABLES AFFECTING FUSION OUTCOMES AND COSTS
icon-1.png patient's age
icon-2.png patient's health
can't change
green-icon-1.png COST OF PROCEDURE
green-icon-2.png EFFICIENT USE OF TIME
blue-icon-1.png EFFICACIOUS BONE GRAFTING OPTIONS
CAN INFLUENCE
vivigen-advantage.png
VA-icon-1.png VALIDATED BONE CELL VIABILITY
VA-icon-2.png READY TO USE IN 5 MINUTES OR LESS
VA-icon-3.png OSTEOGENIC OSTEOCONDUCTIVE OSTEOINDUCTIVE
clinical-impact.png
economic-value.png
 
  1. Data on file LifeNet Health 65-0347
  2. Hall JF, McLean JB, Jones SM, Moore MA, Nicholson MD, Dorsch KA. Multilevel instrumented posterolateral lumbar spine fusion with an allogeneic cellular bone graft. J Orthop Surg Res. 2019;14(1):372. Published 2019 Nov 15.
  3. Wetzell et al. Hospitalization Cost and Resource Utilization in US Lumbar Fusion Surgeries Using a Cellular Bone Allograft (CBA) versus Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2): A Retrospective Cohort Study. Data on file LifeNet Health 68-10-457
  • Statements and data presented are those of LifeNet Health